Geoff Mcdonough - 27 Mar 2024 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Reporting relationship: Director
Issuer ticker: THRD
Reported as of: 27 Mar 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Mar 2024, 16:10:32 UTC
Prior SEC filing: 17 Jan 2024
Next SEC filing: 17 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Christopher Murphy, Attorney-in-Fact

Key filing fact

Geoff Mcdonough filed Form 4 for Third Harmonic Bio, Inc. (THRD) on 28 Mar 2024.

Key facts

This page summarizes Geoff Mcdonough's Form 4 filing for Third Harmonic Bio, Inc. (THRD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Mar 2024, 16:10.

Change

Previous filing in this sequence was filed on 17 Jan 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THRD transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +60,000
Change %
Price: $0.000000
Shares after: 60,000
Date: 27 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,000
Exercise price: $9.47
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests over a three-year period: 1/36th on April 27, 2024, after which 1/36th of the total shares vest monthly, subject to continued service through each vesting date.